Which hedge funds own ABOS? ACUMEN PHARMACEUTICALS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
19 tracked hedge funds disclosed a position in ABOS (ACUMEN PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $78.9m in total. The largest holder by portfolio weight is RA Capital Management, L.P. at 0.5% of its book. 5 opened a new position this quarter: Spark Investment Management LLC, Bronte Capital Management Pty Ltd., Y-Intercept (Hong Kong) Ltd, Citadel Advisors LLC. 5 exited: Laurion Capital Management LP, Catalyst Funds Management Pty Ltd, Brevan Howard Capital Management LP.
19
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
5
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
5
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$315k
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$1.6m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$78.9m
Combined value
Sum of the holders' reported positions in the security.
1.5%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.